A new "rogue gene" has been shown to be a primary cause of cancer spreading

A new study by British researchers has unveiled what they call a “rogue gene”. This gene is known to assist in the spreading of cancer or disease throughout the body and the scientists believe that with the right drugs, it may be possible to prevent this from spreading throughout the body.

The study took place at the University of East Anglia and the experts firmly believe medicines could be available in less than 10 years to help prevent cancer from spreading throughout the body.

Scientists published the study in Oncogene and explained the “rogue gene” in question to be called WWP2. This gene is present in cancer cells and is an enzyme-type bonding agent.

The gene is also known to deteriorate natural proteins in the body which usually prevent the spread of cancer.

Using lab tests, research teams discovered that when WWP2 was blocked, the protein that it normally breaks down was shown to increase, also effectively preventing the spread of cancer cells.

Many experts believe this is a different approach than typical for treating cancer and believe the potential for success is exciting.

Researchers explain the next step in the process is to develop a drug that can effectively stop this gene.

The same research team that discovered this gene has already begun working to design a drug that can effectively block the gene.